NCT07197827
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07197827
Title A Study of YL242 in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MediLink Therapeutics (Suzhou) Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
US-201 NOT_YET_RECRUITING New Haven Connecticut 06519 United States Details
US-202 NOT_YET_RECRUITING Sarasota Florida 34232 United States Details
US-204 NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
US-206 NOT_YET_RECRUITING Grand Rapids Michigan 49546 United States Details
US-205 NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
US-203 NOT_YET_RECRUITING Houston Texas 77030 United States Details
US-207 NOT_YET_RECRUITING San Antonio Texas 78229 United States Details
AUS-101 NOT_YET_RECRUITING Liverpool New South Wales 2170 Australia Details
AUS-102 NOT_YET_RECRUITING Darlinghurst Victoria 2010 Australia Details
AUS-104 NOT_YET_RECRUITING Fitzroy Victoria 3065 Australia Details
AUS-103 NOT_YET_RECRUITING Heidelberg Victoria 3084 Australia Details
AUS-105 NOT_YET_RECRUITING Nedlands Western Australia 6009 Australia Details
CN-303 NOT_YET_RECRUITING Harbin Heilongjiang 150081 China Details
CN-301 RECRUITING Shanghai Shanghai Municipality 200030 China Details
CN-302 NOT_YET_RECRUITING Hangzhou Zhejiang 310022 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field